retatrutide triple agonist gip glp-1 glucagon Scott Isaacs on X: "#retatrutide is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to # Retatrutide is a triple-agonist (GLP-1
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14




























